Monograph Details
|
|
Respiratory Tract
> Asthma/COPD
|
|
PROVENTIL HFA |
| Manufacturer |
|
Schering Corporation |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
β2-agonist. |
| Generic Name |
|
Albuterol 90 micrograms/inh; metered-dose aerosol; contains hydrofluoroalkane; CFC-free. |
| Indications |
|
Bronchospasm. |
| Adults and Children |
|
<4 years: Use other forms. ≥4 years: 2 inh every 4–6 hrs as needed; 1 inh every 4 hrs may suffice. Exercise-induced bronchospasm: 2 inh 15–30 minutes before exercise. |
| Precautions |
|
Avoid excessive use. Sensitivity to sympathomimetics. Discontinue if paradoxical bronchospasm or cardiovascular effects occur. Cardiovascular disease (eg, coronary insufficiency, arrhythmias, hypertension). Diabetes. Hyperthyroidism. Seizure disorders. Reevaluate periodically. Elderly. Labor & delivery. Pregnancy (Cat.C). Nursing mothers: not recommended. |
| Interactions |
|
Avoid MAOIs, tricyclics within 14 days (increased cardiovascular effects). Oral sympathomimetics: not recommended. Antagonized by β-blockers. Monitor digoxin. Caution with other drugs that may lower serum potassium (eg, diuretics). |
| Adverse Reactions |
|
Tremor, nervousness, headache, dizziness, excitement, insomnia, weakness, tachycardia, epistaxis, hypokalemia, local irritation, paradoxical bronchospasm; immediate hypersensitivity reactions (eg, rash, urticaria, angioedema). |
| How Supplied |
|
Inhalation aerosol—6.7g (200 inh) |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
